Michel G - Search Results

1

The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.

Löhr HF, Elste C, Dienes HP, Michel G, Braun HB, Meyer zum Büschenfelde KH, Gerken G. Löhr HF, et al. Among authors: michel g. J Hepatol. 1996 Sep;25(3):292-300. doi: 10.1016/s0168-8278(96)80114-0. J Hepatol. 1996. PMID: 8895007

2

Hepatitis C virus antibody secretion in vitro by peripheral blood lymphocytes.

Löhr H, Fleischer B, Michel G, Rossol S, Hess G, Meyer zum Büschenfelde KH, Manns M. Löhr H, et al. Among authors: michel g. J Hepatol. 1992 Jan;14(1):112-7. doi: 10.1016/0168-8278(92)90139-g. J Hepatol. 1992. PMID: 1310703

3

In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C.

Löhr HF, Gerken G, Michel G, Braun HB, Meyer zum Büschenfelde KH. Löhr HF, et al. Among authors: michel g. Gastroenterology. 1994 Nov;107(5):1443-8. doi: 10.1016/0016-5085(94)90548-7. Gastroenterology. 1994. PMID: 7523227

4

Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.

Löhr H, Nagel C, Dienes HP, Simpson B, Michel G, Goergen B, Meyer zum Büschenfelde KH, Gerken G. Löhr H, et al. Among authors: michel g. Hepatology. 1994 Dec;20(6):1383-9. doi: 10.1002/hep.1840200602. Hepatology. 1994. PMID: 7526999

5

Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.

Martinelli AL, Brown D, Braun HB, Michel G, Dusheiko GM. Martinelli AL, et al. Among authors: michel g. J Hepatol. 1996 Jan;24(1):21-6. doi: 10.1016/s0168-8278(96)80181-4. J Hepatol. 1996. PMID: 8834020

6

Anti-GOR and hepatitis C virus in autoimmune liver diseases.

Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde KH, Decker R, Manns MP. Michel G, et al. Lancet. 1992 Feb 1;339(8788):267-9. doi: 10.1016/0140-6736(92)91332-3. Lancet. 1992. PMID: 1346282

7

GOR-antibodies in patients with chronic liver disease and hepatocellular carcinoma.

Rehermann B, Schneider A, Michel G, Braun HB, Manns MP. Rehermann B, et al. Among authors: michel g. Z Gastroenterol. 1994 Jul;32(7):396-8. Z Gastroenterol. 1994. PMID: 7975776

8

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.

Vandelli C, Renzo F, Braun HB, Tisminetzky S, Albrecht M, De Palma M, Ranzi A, Di Marco G, Stroffolini T, Baralle F, Ventura E, Michel G. Vandelli C, et al. Among authors: michel g. J Med Virol. 1999 May;58(1):26-34. doi: 10.1002/(sici)1096-9071(199905)58:1<26::aid-jmv4>3.0.co;2-w. J Med Virol. 1999. PMID: 10223542 Clinical Trial.

9

Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection.

Durazzo M, Michel G, Philipp T, Braun HB, Luttig B, Rizzetto M, Manns M. Durazzo M, et al. Among authors: michel g. Int J Clin Lab Res. 1994;24(4):227-9. doi: 10.1007/BF02592469. Int J Clin Lab Res. 1994. PMID: 7894050

10

Anti-GOR and anti-thyroid autoantibodies in patients with chronic hepatitis C.

Tran A, Benzaken S, Braun HB, Fredenrich A, Dreyfus G, Durant J, Hiéronimus S, Quaranta JF, Ouzan D, Michel G. Tran A, et al. Among authors: michel g. Clin Immunol Immunopathol. 1995 Nov;77(2):127-30. doi: 10.1006/clin.1995.1135. Clin Immunol Immunopathol. 1995. PMID: 7586719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,568 results

Search Page

Filters